Qorvo, Inc. (QRVO) director awarded 2,327 shares of common stock

Rhea-AI Filing Summary

Koopmans Chris reported acquisition or exercise transactions in this Form 4 filing.

Qorvo, Inc. director Chris Koopmans reported a compensation-related equity transaction. On 2026-08-12, he received a grant of 2,327 shares of Qorvo common stock at a reported price of $0.00 per share. Following this award, he holds 6,160 shares of Qorvo common stock directly.

Insider Trade Summary

Net Buyer: 2,327 shares

Net Buy 1 txn

Insider Koopmans Chris

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,327	$0.00	$0.00

Holdings After Transaction: Common Stock — 6,160 shares (Direct)

Key Figures

Shares granted: 2,327 shares Price per share: $0.00 Shares owned after transaction: 6,160 shares +2 more

5 metrics

Shares granted 2,327 shares Non-derivative common stock grant on 2026-08-12

Price per share $0.00 Reported transaction price for the 2,327-share grant

Shares owned after transaction 6,160 shares Direct holdings of Chris Koopmans following the grant

Transactions acquiring shares 1 AcquireCount in transaction summary

Transactions disposing shares 0 SellCount and disposeCount in transaction summary

Key Terms

Grant, award, or other acquisition, non-derivative, direct ownership

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

non-derivative financial

"transaction_type: non-derivative"

direct ownership financial

"ownership_type: direct"

FAQ

What insider transaction did Qorvo (QRVO) director Chris Koopmans report?

Chris Koopmans reported a grant of 2,327 shares of Qorvo common stock on 2026-08-12. The transaction is coded as a grant or award, indicating a compensation-related share acquisition rather than a market purchase.

How many Qorvo (QRVO) shares does Chris Koopmans hold after this transaction?

After the reported grant, Chris Koopmans directly holds 6,160 Qorvo common shares. This total includes the newly awarded 2,327 shares and reflects his position immediately following the 2026-08-12 equity grant.

Was the Qorvo (QRVO) insider transaction by Chris Koopmans a purchase or a grant?

The filing classifies the transaction as a grant, award, or other acquisition of 2,327 common shares, not a market purchase. The reported price is $0.00 per share, consistent with a stock award as part of director compensation.

Did Qorvo (QRVO) director Chris Koopmans sell any shares in this Form 4 filing?

No. The Form 4 for Chris Koopmans reports only an acquisition of 2,327 shares via grant and shows no sales or dispositions. The transaction summary lists acquireCount as 1 and sellCount as 0.

Is the Qorvo (QRVO) insider transaction by Chris Koopmans related to derivatives or options?

No derivative transactions are reported. The filing shows a non-derivative common stock grant of 2,327 shares, and the derivativeSummary section is empty, indicating no option or other derivative exercises in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 05:03 PM Accepted by SEC EDGAR 08/13/2026 - 05:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

C/O QORVO, INC.

7628 THORNDIKE ROAD

(Street)

GREENSBORO NORTH CAROLINA 27409

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Qorvo, Inc. [ QRVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		A		2,327	A	$0	6,160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jason T. Gray, by Power of Attorney	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)